The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Anagrelide hydrochloride
Australian Public Assessment Report
Device/Product Name
Thromboreductin
Active ingredients
Anagrelide hydrochloride
AusPAR Date
Published
Sponsor
Submission Number
PM-2009-03102-3-4
Submission Type
Orphan drug